Sociologist Jake Rosenfeld has a lot to say about the taboo subject of pay.
Jewish books stolen by Nazis during World War II are returned to Prague — by way of Washington University Libraries.
The COVID-19 pandemic opened our eyes to the fragility of our pharmaceutical supply chain. Olin research provides a path forward to secure it.
The story of E.G. Lewis is the backdrop of a novel by Doug Villhard, academic director of entrepreneurship at Olin Business School. Lewis, the founder of nearby University City, was a turn-of-the-century entrepreneur and salesman who knew his customers.
The Osher Lifelong Learning Institute (OLLI) offers students ages 50 and older intellectually challenging courses and camaraderie. Recently discovered photos and essays from an OLLI memoir writing course emphasize the gift of lifelong learning.
An archival rescue operation helps save decades of Assembly Series lectures, providing opportunities to hear important voices of the past.
Robyn LeBoeuf, professor of marketing at Olin Business School, searches how people’s time perceptions affect the way they make decisions.
The Brown School’s Darrell Hudson digs deep into data and researches how social determinants like racism affect multiple health outcomes, especially among Black Americans.
Aduhelm, the first new Alzheimer’s drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works.
Genetic testing has become so commonplace that you can send off a swab to 23andme.com and for $200 find out your genetic health risks. The problem, aside from the fact that not all genetic testing is accurate, is that genetic test results must be interpreted.
View More Stories